Structure

Physi-Chem Properties

Molecular Weight:  314.04
Volume:  297.426
LogP:  1.681
LogD:  1.715
LogS:  -3.777
# Rotatable Bonds:  2
TPSA:  114.04
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.802
Synthetic Accessibility Score:  2.948
Fsp3:  0.062
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.1
MDCK Permeability:  1.676832471275702e-05
Pgp-inhibitor:  0.007
Pgp-substrate:  0.002
Human Intestinal Absorption (HIA):  0.095
20% Bioavailability (F20%):  0.927
30% Bioavailability (F30%):  0.146

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  90.84166717529297%
Volume Distribution (VD):  0.41
Pgp-substrate:  6.811251640319824%

ADMET: Metabolism

CYP1A2-inhibitor:  0.983
CYP1A2-substrate:  0.673
CYP2C19-inhibitor:  0.709
CYP2C19-substrate:  0.055
CYP2C9-inhibitor:  0.863
CYP2C9-substrate:  0.872
CYP2D6-inhibitor:  0.905
CYP2D6-substrate:  0.19
CYP3A4-inhibitor:  0.74
CYP3A4-substrate:  0.082

ADMET: Excretion

Clearance (CL):  3.613
Half-life (T1/2):  0.906

ADMET: Toxicity

hERG Blockers:  0.038
Human Hepatotoxicity (H-HT):  0.837
Drug-inuced Liver Injury (DILI):  0.518
AMES Toxicity:  0.36
Rat Oral Acute Toxicity:  0.888
Maximum Recommended Daily Dose:  0.918
Skin Sensitization:  0.821
Carcinogencity:  0.843
Eye Corrosion:  0.02
Eye Irritation:  0.707
Respiratory Toxicity:  0.517

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC25427

Natural Product ID:  NPC25427
Common Name*:   5-Hydroxybowdichione
IUPAC Name:   2-(5,7-dihydroxy-4-oxochromen-3-yl)-5-methoxycyclohexa-2,5-diene-1,4-dione
Synonyms:   5-Hydroxybowdichione
Standard InCHIKey:  XTAGXYXCZYACHC-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C16H10O7/c1-22-13-5-10(18)8(4-11(13)19)9-6-23-14-3-7(17)2-12(20)15(14)16(9)21/h2-6,17,20H,1H3
SMILES:  COC1=CC(=O)C(=CC1=O)c1coc2cc(cc(c2c1=O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL478972
PubChem CID:   5491730
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0000144] Chromones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13784 Dalbergia candenatensis Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[19653666]
NPO13784 Dalbergia candenatensis Species Fabaceae Eukaryota n.a. Thai n.a. PMID[3430167]
NPO13784 Dalbergia candenatensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC > 100.0 ug.mL-1 PMID[521915]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 100.0 ug.mL-1 PMID[521915]
NPT19 Organism Escherichia coli Escherichia coli MIC = 50.0 ug.mL-1 PMID[521915]
NPT20 Organism Candida albicans Candida albicans MIC > 100.0 ug.mL-1 PMID[521915]
NPT3086 Organism Penicillium expansum Penicillium expansum MIC > 100.0 ug.mL-1 PMID[521915]
NPT21 Organism Aspergillus niger Aspergillus niger MIC > 100.0 ug.mL-1 PMID[521915]
NPT330 Organism Trichophyton mentagrophytes Trichophyton mentagrophytes MIC = 100.0 ug.mL-1 PMID[521915]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC25427 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9925 High Similarity NPC49242
0.9338 High Similarity NPC294409
0.9338 High Similarity NPC162680
0.9338 High Similarity NPC7013
0.9338 High Similarity NPC181124
0.9338 High Similarity NPC116632
0.9338 High Similarity NPC303644
0.9338 High Similarity NPC209560
0.9323 High Similarity NPC65060
0.927 High Similarity NPC12175
0.927 High Similarity NPC279668
0.927 High Similarity NPC309154
0.927 High Similarity NPC278323
0.927 High Similarity NPC90665
0.927 High Similarity NPC55162
0.9214 High Similarity NPC473813
0.9214 High Similarity NPC473812
0.9209 High Similarity NPC136840
0.9203 High Similarity NPC295384
0.9191 High Similarity NPC234560
0.9191 High Similarity NPC39426
0.9173 High Similarity NPC185497
0.9149 High Similarity NPC472446
0.9149 High Similarity NPC472447
0.9137 High Similarity NPC59951
0.9137 High Similarity NPC48624
0.9137 High Similarity NPC219917
0.9137 High Similarity NPC204985
0.9137 High Similarity NPC269652
0.9137 High Similarity NPC213659
0.9137 High Similarity NPC259166
0.9137 High Similarity NPC184536
0.9137 High Similarity NPC103904
0.9137 High Similarity NPC172250
0.9137 High Similarity NPC253822
0.9137 High Similarity NPC146679
0.9137 High Similarity NPC103342
0.9137 High Similarity NPC281207
0.9137 High Similarity NPC230285
0.9137 High Similarity NPC101366
0.9137 High Similarity NPC215311
0.9137 High Similarity NPC144118
0.9137 High Similarity NPC80962
0.9137 High Similarity NPC326109
0.9124 High Similarity NPC87545
0.9124 High Similarity NPC235428
0.9124 High Similarity NPC193792
0.9118 High Similarity NPC286336
0.9111 High Similarity NPC257756
0.9111 High Similarity NPC205468
0.9111 High Similarity NPC129132
0.9111 High Similarity NPC87231
0.9111 High Similarity NPC212631
0.9098 High Similarity NPC212379
0.9098 High Similarity NPC60558
0.9098 High Similarity NPC69235
0.9091 High Similarity NPC128428
0.9091 High Similarity NPC305518
0.9085 High Similarity NPC470458
0.9078 High Similarity NPC158874
0.9071 High Similarity NPC52789
0.9071 High Similarity NPC90582
0.9071 High Similarity NPC26051
0.9071 High Similarity NPC469404
0.9071 High Similarity NPC262094
0.9071 High Similarity NPC55832
0.9071 High Similarity NPC268204
0.9065 High Similarity NPC469523
0.9065 High Similarity NPC283429
0.9065 High Similarity NPC241838
0.9065 High Similarity NPC143799
0.9065 High Similarity NPC152042
0.9058 High Similarity NPC250266
0.9058 High Similarity NPC212767
0.9058 High Similarity NPC266597
0.9051 High Similarity NPC60667
0.9044 High Similarity NPC82225
0.9044 High Similarity NPC242294
0.9044 High Similarity NPC56031
0.9044 High Similarity NPC337373
0.9044 High Similarity NPC18877
0.9044 High Similarity NPC204960
0.9044 High Similarity NPC28753
0.9044 High Similarity NPC20560
0.9044 High Similarity NPC263670
0.9044 High Similarity NPC192304
0.9044 High Similarity NPC294593
0.9044 High Similarity NPC159623
0.9044 High Similarity NPC144051
0.9044 High Similarity NPC472365
0.9044 High Similarity NPC188646
0.9044 High Similarity NPC223457
0.9044 High Similarity NPC312318
0.9044 High Similarity NPC139813
0.9044 High Similarity NPC175098
0.9037 High Similarity NPC31872
0.9037 High Similarity NPC473584
0.9037 High Similarity NPC64359
0.9037 High Similarity NPC308037
0.9037 High Similarity NPC262359
0.9037 High Similarity NPC475589
0.9037 High Similarity NPC313618
0.9023 High Similarity NPC186098
0.9023 High Similarity NPC80694
0.9007 High Similarity NPC204469
0.8993 High Similarity NPC188947
0.8993 High Similarity NPC99333
0.8993 High Similarity NPC124269
0.8993 High Similarity NPC280284
0.8986 High Similarity NPC150399
0.8986 High Similarity NPC274109
0.8986 High Similarity NPC240147
0.8986 High Similarity NPC477243
0.8986 High Similarity NPC124784
0.8986 High Similarity NPC121243
0.8986 High Similarity NPC25287
0.8986 High Similarity NPC249606
0.8986 High Similarity NPC473887
0.8986 High Similarity NPC1486
0.8986 High Similarity NPC12165
0.8986 High Similarity NPC98115
0.8986 High Similarity NPC174999
0.8986 High Similarity NPC29353
0.8986 High Similarity NPC66349
0.8986 High Similarity NPC234133
0.8986 High Similarity NPC47815
0.8986 High Similarity NPC168105
0.8986 High Similarity NPC127447
0.8986 High Similarity NPC186838
0.8986 High Similarity NPC194281
0.8986 High Similarity NPC41461
0.8986 High Similarity NPC477242
0.8986 High Similarity NPC477244
0.8986 High Similarity NPC231772
0.8978 High Similarity NPC125920
0.8978 High Similarity NPC164136
0.8978 High Similarity NPC144027
0.8978 High Similarity NPC236974
0.8971 High Similarity NPC182428
0.8971 High Similarity NPC25937
0.8971 High Similarity NPC10971
0.8971 High Similarity NPC203817
0.8963 High Similarity NPC5515
0.8963 High Similarity NPC270369
0.8963 High Similarity NPC250057
0.8958 High Similarity NPC470460
0.8955 High Similarity NPC230818
0.8951 High Similarity NPC306488
0.8951 High Similarity NPC5820
0.8951 High Similarity NPC178343
0.8951 High Similarity NPC329678
0.8944 High Similarity NPC475705
0.8944 High Similarity NPC470216
0.8944 High Similarity NPC245482
0.8944 High Similarity NPC51887
0.8944 High Similarity NPC301751
0.8944 High Similarity NPC117836
0.8944 High Similarity NPC475201
0.8944 High Similarity NPC476178
0.8936 High Similarity NPC110969
0.8936 High Similarity NPC3188
0.8929 High Similarity NPC140890
0.8929 High Similarity NPC222342
0.8929 High Similarity NPC329203
0.8929 High Similarity NPC265871
0.8929 High Similarity NPC150648
0.8929 High Similarity NPC230902
0.8929 High Similarity NPC78913
0.8929 High Similarity NPC274784
0.8929 High Similarity NPC225153
0.8929 High Similarity NPC18260
0.8929 High Similarity NPC23257
0.8929 High Similarity NPC310135
0.8929 High Similarity NPC470211
0.8929 High Similarity NPC139554
0.8929 High Similarity NPC201541
0.8929 High Similarity NPC20709
0.8929 High Similarity NPC473076
0.8929 High Similarity NPC261234
0.8921 High Similarity NPC317119
0.8921 High Similarity NPC290291
0.8921 High Similarity NPC299379
0.8921 High Similarity NPC188879
0.8921 High Similarity NPC472419
0.8921 High Similarity NPC275055
0.8921 High Similarity NPC228661
0.8921 High Similarity NPC153979
0.8913 High Similarity NPC156092
0.8913 High Similarity NPC131039
0.8913 High Similarity NPC13575
0.8905 High Similarity NPC108113
0.8905 High Similarity NPC223354
0.8905 High Similarity NPC93756
0.8897 High Similarity NPC189106
0.8897 High Similarity NPC186097
0.8897 High Similarity NPC475009
0.8897 High Similarity NPC112192
0.8897 High Similarity NPC475008
0.8897 High Similarity NPC164236
0.8897 High Similarity NPC66384

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC25427 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9191 High Similarity NPD1510 Phase 2
0.9037 High Similarity NPD1240 Approved
0.8905 High Similarity NPD1607 Approved
0.8881 High Similarity NPD4378 Clinical (unspecified phase)
0.8857 High Similarity NPD1549 Phase 2
0.8786 High Similarity NPD1550 Clinical (unspecified phase)
0.8786 High Similarity NPD1552 Clinical (unspecified phase)
0.8582 High Similarity NPD2796 Approved
0.8552 High Similarity NPD6799 Approved
0.8493 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8487 Intermediate Similarity NPD7075 Discontinued
0.8472 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8467 Intermediate Similarity NPD6801 Discontinued
0.8462 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8456 Intermediate Similarity NPD4380 Phase 2
0.8411 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8369 Intermediate Similarity NPD6651 Approved
0.8333 Intermediate Similarity NPD6599 Discontinued
0.8311 Intermediate Similarity NPD1512 Approved
0.8301 Intermediate Similarity NPD3882 Suspended
0.8278 Intermediate Similarity NPD7411 Suspended
0.8224 Intermediate Similarity NPD1934 Approved
0.8219 Intermediate Similarity NPD3750 Approved
0.8176 Intermediate Similarity NPD1511 Approved
0.817 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8151 Intermediate Similarity NPD2800 Approved
0.8133 Intermediate Similarity NPD5403 Approved
0.8129 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD5401 Approved
0.8117 Intermediate Similarity NPD3817 Phase 2
0.8117 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD2801 Approved
0.8052 Intermediate Similarity NPD7819 Suspended
0.8012 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7945 Intermediate Similarity NPD1551 Phase 2
0.7937 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7937 Intermediate Similarity NPD6166 Phase 2
0.7937 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7905 Intermediate Similarity NPD1243 Approved
0.7905 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD2532 Approved
0.7881 Intermediate Similarity NPD2534 Approved
0.7881 Intermediate Similarity NPD2533 Approved
0.7877 Intermediate Similarity NPD3748 Approved
0.7877 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7834 Intermediate Similarity NPD7768 Phase 2
0.7832 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7823 Intermediate Similarity NPD2935 Discontinued
0.7805 Intermediate Similarity NPD6797 Phase 2
0.7785 Intermediate Similarity NPD2654 Approved
0.7785 Intermediate Similarity NPD3749 Approved
0.7778 Intermediate Similarity NPD920 Approved
0.7771 Intermediate Similarity NPD5402 Approved
0.777 Intermediate Similarity NPD2344 Approved
0.7758 Intermediate Similarity NPD7251 Discontinued
0.775 Intermediate Similarity NPD6959 Discontinued
0.7748 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7736 Intermediate Similarity NPD919 Approved
0.773 Intermediate Similarity NPD3818 Discontinued
0.7724 Intermediate Similarity NPD943 Approved
0.7711 Intermediate Similarity NPD7808 Phase 3
0.7702 Intermediate Similarity NPD6232 Discontinued
0.7676 Intermediate Similarity NPD2798 Approved
0.7669 Intermediate Similarity NPD7473 Discontinued
0.7664 Intermediate Similarity NPD9545 Approved
0.7647 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD9493 Approved
0.7643 Intermediate Similarity NPD9717 Approved
0.764 Intermediate Similarity NPD1247 Approved
0.761 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD1203 Approved
0.7605 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD5953 Discontinued
0.7576 Intermediate Similarity NPD7054 Approved
0.7571 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD422 Phase 1
0.7566 Intermediate Similarity NPD2309 Approved
0.7551 Intermediate Similarity NPD230 Phase 1
0.7536 Intermediate Similarity NPD1548 Phase 1
0.753 Intermediate Similarity NPD7472 Approved
0.753 Intermediate Similarity NPD7074 Phase 3
0.7517 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7286 Phase 2
0.7469 Intermediate Similarity NPD5494 Approved
0.7467 Intermediate Similarity NPD6099 Approved
0.7467 Intermediate Similarity NPD6100 Approved
0.7466 Intermediate Similarity NPD2313 Discontinued
0.7448 Intermediate Similarity NPD6832 Phase 2
0.7439 Intermediate Similarity NPD3926 Phase 2
0.7426 Intermediate Similarity NPD1241 Discontinued
0.74 Intermediate Similarity NPD2799 Discontinued
0.74 Intermediate Similarity NPD7033 Discontinued
0.7394 Intermediate Similarity NPD3972 Approved
0.7386 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD4628 Phase 3
0.7381 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD7390 Discontinued
0.7347 Intermediate Similarity NPD3268 Approved
0.7342 Intermediate Similarity NPD3226 Approved
0.7337 Intermediate Similarity NPD6559 Discontinued
0.7329 Intermediate Similarity NPD4908 Phase 1
0.7325 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD1610 Phase 2
0.7305 Intermediate Similarity NPD3751 Discontinued
0.7289 Intermediate Similarity NPD2403 Approved
0.7285 Intermediate Similarity NPD4308 Phase 3
0.7273 Intermediate Similarity NPD5710 Approved
0.7273 Intermediate Similarity NPD5711 Approved
0.7257 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD1470 Approved
0.7241 Intermediate Similarity NPD2797 Approved
0.723 Intermediate Similarity NPD6798 Discontinued
0.723 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD1296 Phase 2
0.7222 Intermediate Similarity NPD4288 Approved
0.72 Intermediate Similarity NPD5124 Phase 1
0.72 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD1019 Discontinued
0.719 Intermediate Similarity NPD1471 Phase 3
0.7186 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD3225 Approved
0.7172 Intermediate Similarity NPD1876 Approved
0.716 Intermediate Similarity NPD1465 Phase 2
0.716 Intermediate Similarity NPD5844 Phase 1
0.7143 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD9494 Approved
0.7135 Intermediate Similarity NPD6104 Discontinued
0.7125 Intermediate Similarity NPD7458 Discontinued
0.7123 Intermediate Similarity NPD3267 Approved
0.7123 Intermediate Similarity NPD3266 Approved
0.7118 Intermediate Similarity NPD1729 Discontinued
0.7115 Intermediate Similarity NPD2354 Approved
0.7114 Intermediate Similarity NPD411 Approved
0.7114 Intermediate Similarity NPD3764 Approved
0.7113 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD4749 Approved
0.7086 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1933 Approved
0.7086 Intermediate Similarity NPD447 Suspended
0.7083 Intermediate Similarity NPD1201 Approved
0.7079 Intermediate Similarity NPD4360 Phase 2
0.7079 Intermediate Similarity NPD4363 Phase 3
0.7078 Intermediate Similarity NPD2346 Discontinued
0.7059 Intermediate Similarity NPD9266 Approved
0.7059 Intermediate Similarity NPD74 Approved
0.7039 Intermediate Similarity NPD4361 Phase 2
0.7039 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.702 Intermediate Similarity NPD4307 Phase 2
0.7012 Intermediate Similarity NPD2296 Approved
0.7007 Intermediate Similarity NPD1164 Approved
0.7006 Intermediate Similarity NPD3887 Approved
0.7 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.6985 Remote Similarity NPD9267 Approved
0.6985 Remote Similarity NPD9264 Approved
0.6985 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6985 Remote Similarity NPD9263 Approved
0.6974 Remote Similarity NPD6355 Discontinued
0.6968 Remote Similarity NPD2353 Approved
0.6968 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6959 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6954 Remote Similarity NPD6233 Phase 2
0.6943 Remote Similarity NPD7003 Approved
0.6933 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6933 Remote Similarity NPD3027 Phase 3
0.6932 Remote Similarity NPD8434 Phase 2
0.6923 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6918 Remote Similarity NPD1608 Approved
0.6918 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6918 Remote Similarity NPD9269 Phase 2
0.6913 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6908 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6908 Remote Similarity NPD3140 Approved
0.6908 Remote Similarity NPD3142 Approved
0.6908 Remote Similarity NPD1613 Approved
0.6903 Remote Similarity NPD5404 Approved
0.6903 Remote Similarity NPD5405 Approved
0.6903 Remote Similarity NPD5406 Approved
0.6903 Remote Similarity NPD5408 Approved
0.6899 Remote Similarity NPD6190 Approved
0.6885 Remote Similarity NPD6776 Approved
0.6885 Remote Similarity NPD6778 Approved
0.6885 Remote Similarity NPD6780 Approved
0.6885 Remote Similarity NPD6777 Approved
0.6885 Remote Similarity NPD6781 Approved
0.6885 Remote Similarity NPD6779 Approved
0.6885 Remote Similarity NPD6782 Approved
0.6879 Remote Similarity NPD1652 Phase 2
0.6875 Remote Similarity NPD9268 Approved
0.6875 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6866 Remote Similarity NPD940 Approved
0.6866 Remote Similarity NPD846 Approved
0.6865 Remote Similarity NPD7435 Discontinued
0.6864 Remote Similarity NPD3787 Discontinued
0.6859 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6854 Remote Similarity NPD4287 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data